The greatest increase in gradient at reevaluation was 14 mm Hg. Twenty of 27 patients (74%) had no change in the degree of aortic insufficiency at follow-up compared with that present before valvuloplasty. At follow-up, 16 patients had no aortic insufficiency at all, and only two had moderate-to-severe (3-4+) insufficiency. Femoral Figure 2 ) remained significantly reduced at the follow-up study compared with that before valvuloplasty: 138-+4 versus 176 +4 mm Hg (p<0.001). Further, there was no significant change in left ventricular systolic pressure at follow-up compared with that immediately after valvuloplasty (p=NS). The left ventricular end-diastolic pressure at follow-up was not significantly different from that measured immediately after valvuloplasty (p=NS).
At the follow-up catheterization, 20 of 27 patients (74%) had no increase in aortic insufficiency compared with that present before valvuloplasty (see Figure 3) . Of the seven patients with increased aortic insufficiency, two had a 1 + increase and five had a 2+ increase in aortic insufficiency at late follow-up. In four of these seven patients, the aortic insufficiency produced acutely after valvuloplasty had not progressed, whereas in three patients the insufficiency had increased at follow-up (a 1 + increase in two, a 2+ increase in one). Perhaps most important, an average of 1.7 years after valvuloplasty 16 patients had no aortic insufficiency at all, and only two had moderate-to-severe (3-4+) aortic insufficiency.
Stepwise multiple regression analysis identified effective balloon/annulus ratio and prevalvuloplasty peak AS gradient as the only significant predictors of absolute gradient reduction at the follow-up evaluation (Y= -69+63.6X1+0.69X2, r=0.82, F=25; where Y is gradient reduction in millimeters of mercury, X1 is effective balloon/annulus ratio, and X2 is AS gra- Femoral artery injury, either occlusion or stenosis, was observed at follow-up in four of 27 patients. This occurred in three of five children under 12 months of age, but in only one of 22 patients older than 12 months of age at the time of valvuloplasty (Fisher exact, p=0.01). Vessels in the remaining patients appeared to be intact, based on lack of symptoms, presence of symmetric, easily palpable pulses, and the ability to easily recannulate the arteries at the follow-up catheterization. Thus, femoral artery occlusion or stenosis occurred in 60% of infants undergoing valvuloplasty but in less than 5% of older patients. Since femoral arteriography was not performed in this study, it is possible that some arterial stenoses may have gone undetected. Discussion PBAV was originally described as treatment for congenital valvar AS in children. [1] [2] [3] [4] [5] The excellent early outcome in this population led to application of the procedure in elderly patients with calcific AS. Due to the large patient population available, all systematic follow-up studies evaluating the late effectiveness of PBAV have been in the elderly population. Unfortunately, these follow-up studies have documented a high incidence of early restenosis and late mortality after PBAV in adults with calcific AS.6-12 It is unwarranted, however, to extrapolate these data to the pediatric population with congenital AS since different morphological substrates underlie each defect.
The present study is the first systematic, complete (90% follow-up), invasive evaluation of the intermediate-term effectiveness of PBAV in children with congenital valvar AS. It has documented substantial gradient relief without significant restenosis an average of 1.7 years after PBAV. The peak systolic AS gradient was reduced from 76±4 mm Hg before valvuloplasty to 29±3 mm Hg at intermediate followup, a 62% reduction. The greatest increase in gradient at follow-up was 14 mm Hg, occurring in two children. These data stand in marked contrast with the high incidence of restenosis reported in adults with calcific AS. They indicate that PBAV provides effective intermediate-term gradient relief, and that early restenosis is uncommon after PBAV in children and adolescents with congenital AS.
The patient population reported in this study represents all children and adolescents requiring intervention for congenital valvar AS at our institution between July 1985 and June 1988. During this interval, all patients chose to undergo balloon valvuloplasty rather than surgical valvotomy. The study group is therefore likely to be a representative sample of children with significant valvar AS. A second strength of the study is the nearly complete inclusion (90%) of all children available for intermediate follow-up evaluation. No clinical or acute hemodynamic factors differentiate the three children not enrolling in the follow-up study from the other 27 patients (see Table 1 ). Thus, it is unlikely that sampling bias has significantly affected the follow-up hemodynamic findings. Finally, the hemodynamic measurements in this study were obtained using consistent methods over a follow-up interval of almost 2 years. At each study, the peak AS gradient was measured directly from simultaneous left ventricular and aortic pressure tracings, cardiac output was measured by thermodilution technique, and aortic insufficiency was quantified angiographically.
Several previous reports of balloon valvuloplasty in children with AS have included short or intermediate-term follow-up data on some patients. [1] [2] [3] [4] [5] 19, 20 As follow-up studies, however, these reports are incomplete because they have presented late hemodynamic data in only a minority of their patients. Vogel and colleagues, for example, provided intermediate-term hemodynamic data on nine of 25 children after PBAV. 19 In these children the Doppler-estimated AS gradient was 41 mm Hg immediately after valvuloplasty and 30 mm Hg an average of 9 months later, suggesting no early restenosis in the group sampled. Other studies have used inconsistent methods of gradient assessment, making it difficult to determine the true degree of restenosis that may have occurred. The report by Shaddy, presenting data in 17 of 32 patients with congenital AS, suggested that early restenosis may have occurred.20 The catheter-measured peak systolic AS gradient decreased acutely by 70% after valvuloplasty, but follow-up Doppler studies later documented a gradient reduction of only 40%. Direct comparison of catheter peak-to-peak and Doppler peak instantaneous gradients to assess late effectiveness may be misleading, however, since the two gradients may differ substantially in patients with aortic stenosis.21,22 The present study employs only serial catheter-determined peak AS gradients.
The degree of intermediate-term gradient relief documented in the current study closely resembles that previously reported after surgical valvotomy. [23] [24] [25] [26] [27] In the "Natural History Study"23 and the follow-up study of Jones and coworkers,24 a combined total of 60 children were systematically reevaluated 1-2 years after surgical aortic valvotomy. At cardiac catheterization the residual peak systolic AS gradient averaged 28 mm Hg. Twenty-five of the 34 patients reevaluated by Jones had aortic insufficiency, with moderate-to-severe insufficiency described in 15 of these 34 patients (44%). Comparison of these published data with those of the current follow-up study indicates that the intermediate-term gradient reduction and risk of aortic insufficiency after balloon valvuloplasty are similar to those of surgical valvotomy. With PBAV, however, the inherent risks of anesthesia, thoracotomy, and cardiopulmonary bypass are eliminated.
The major complications in this series were the development of moderate-to-severe aortic insufficiency and femoral artery injury. Moderate-to-severe aortic insufficiency (3-4+) developed in only two of 27 patients (Table 1 , patients 12 and 15). In these two patients the effective balloon/annulus ratio was 0.90 and 0.92. The data in our study did not reveal a relation between the balloon/annulus ratio and the development of new aortic insufficiency after valvuloplasty. However, in the larger registry study,28 which evaluated the acute effectiveness of PBAV in 204 children with congenital AS, aortic insufficiency was found to develop more commonly when the balloon/annulus ratio exceeded 1.0. This difference in findings may be attributable to the smaller sample size of the current study. Other factors, in addition to balloon/annulus ratio, may contribute to the risk of new aortic insufficiency after balloon valvuloplasty. Sholler and associates29 have postulated that valve morphology, specifically commissural development and leaflet thickness, influence the occurrence of valvuloplasty-induced aortic insufficiency. These variables, however, were not evaluated in the current study and warrant further investigation.
Femoral artery injury was noted more commonly in children under 12 months of age at valvuloplasty (incidence, 60%; 90% confidence intervals, 27-86%). The infant population is at a higher risk of arterial injury because the ratio of catheter diameter to vessel lumen is large. During the study period, PBAV was attempted in two additional infants but could not be performed because of lack of suitable arterial access for the large valvuloplasty catheters used at that time. The development of smaller catheters may reduce the incidence of femoral artery injury in infants undergoing valvuloplasty in the future. Further studies using quantitative methods to evaluate femoral artery injury after valvuloplasty are necessary, particularly in infants undergoing valvuloplasty within the first year of life.
Conclusions and Recommendations
Balloon valvuloplasty provides effective intermediate-term gradient reduction in children and adolescents with congenital valvar AS. This is in marked contrast with the high incidence of early restenosis after valvuloplasty in adults with acquired calcific AS. The current study has shown that gradient reduction persists at an average follow-up of 1.7 years, without significant restenosis and without severe aortic insufficiency in the majority of children. Furthermore, the residual AS gradient and the risk of aortic insufficiency after PBAV appear remarkably similar to that described after surgical valvotomy. Since PBAV does not require general anesthesia, thoracotomy, or cardiopulmonary bypass and is associated with a shorter hospital stay compared with surgery, it should replace surgical valvotomy as the treatment of choice for children and adolescents with congenital valvar AS.
